ICN acquires Siemens' dosimetry service:
This article was originally published in Clinica
ICN Pharmaceuticals has acquired Siemens' dosimetry service business division for an undisclosed amount, following US regulatory clearance. ICN says the purchase will allow it to expand its radiation detection service from the US into international markets. The dosimetry service, which is part of Siemens Medical Systems, had worldwide revenues of $9.3 million in fiscal 1995. Global sales for dosimetry services were around $200 million in 1994.
You may also be interested in...
Drawing on 24 years as a legislator and another 16 years as a leading lobbyist for biopharma, Jim Greenwood sees an opportunity for industry to put drug pricing ‘behind us’ with a legislative compromise.
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
No device-related warning letters were released by the US FDA the week of 19 January.